Assistant Professor of Surgery
Mass General Brigham
Harvard Medical School
Leveraging quantitative research and health system innovation to improve patient outcomes for patients with complex pancreatic and hepatobiliary cancers.
View Publications →
I am an Assistant Professor of Surgery in the Department of Surgery, Division of Surgical Oncology, at Mass General Brigham (Brigham and Women's Hospital) at Harvard Medical School, where I lead a research program focused on improving patient outcomes through health system innovation and advanced quantitative methods, at the intersection of public health, data science, and care delivery.
My team investigates how fragmentation of cancer care impacts outcomes for patients with complex pancreatic and hepatobiliary cancers. We also develop and evaluate novel approaches that leverage large administrative datasets to emulate randomized clinical trials.
I obtained an MPH in Quantitative Methods from the Harvard T.H. Chan School of Public Health (HSPH). As part of my training in General Surgery at Massachusetts General Hospital, I completed a two-year post-graduate research fellowship at Ariadne Labs, a joint health systems innovation center of BWH and HSPH. I then completed the Mass General Brigham/Dana-Farber Complex General Surgical Oncology Fellowship at Harvard Medical School.
I am committed to open science, rigorous methodology, and the mentorship of the next generation of health services researchers. I currently serve on the editorial advisory boards of The American Journal of Surgery and Annals of Surgical Oncology (Hepatobiliary Tumors Section).
This study evaluates the benefit of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma who achieve a pathologic complete response after neoadjuvant treatment, using the National Cancer Database.
Using target trial emulation in the National Cancer Database to estimate the per-protocol effect of neoadjuvant chemotherapy followed by surgery versus upfront surgery followed by adjuvant chemotherapy on overall survival among patients with resectable pancreatic ductal adenocarcinoma.
Evaluating the association between neoadjuvant radiation and margin status and local recurrence among patients with pancreatic ductal adenocarcinoma of the head of the pancreas who underwent curative-intent surgery at a high-volume cancer center.
Characterizing how multidisciplinary metastatic colorectal cancer programs are structured and implemented across U.S. cancer centers and identifying key factors that facilitate or hinder their establishment and sustainability, with the long-term objective of improving equitable access to high-quality multidisciplinary care.
An in-depth analysis of health care spending and utilization for individuals with cancer, assessing use of various cancer treatments, clinical outcomes, and opportunities for high-value care delivery.
Emily E. Witt, MD, MSC · Gezzer Ortega, MD, MPH · George Molina, MD, MPH
An exploration of how AI could be used to help improve practice efficiency, care coordination, equity, and disseminate models for multidisciplinary care for patients with metastatic colorectal cancer.
George Molina, MD, MPH · Alexander Hannenberg · Rachel Smith · Joaquim Havens · Thomas Stelfox · Eddy Lang · Laura V. Duncan · Susan Haas · Jason Pradarelli · Nikhil Panda · Yves Sonnay · Christy Cauley · Evan Benjamin · Mary E. Brindle
An outline of important principles that may help organizations guide the formulation of human resource contingency plans should a surge of critically ill patients occur in your specific institution.
Every patient facing a complex cancer diagnosis deserves access to timely, evidence-based, and compassionate care. Our research program is dedicated to advancing surgical oncology through innovation in clinical care, health services research, multidisciplinary collaboration, and patient-centered outcomes research.
Philanthropic contributions directly support research personnel, data resources, patient-centered initiatives, educational programs, and the development of new ideas that can transform cancer care delivery.
Together, we can create a future where cancer care is more equitable, coordinated, innovative, and effective for every patient and family.
To learn more about supporting our work or making a contribution, please contact us below. Your partnership can make a meaningful and lasting impact.
Please fill out the form below and I will be in touch.